Answers are grounded in this paper and cite their sources.
Whether nicotinic acid use becomes routine in the treatment of atherosclerosis is likely to be determined by the results of two ongoing clinical outcome trials. In addition, further research is required to explore the 'pleiotropic' effects of nicotinic acid and will ultimately provide a platform for the development of newer molecules that are potentially beneficial but without the well known side-effects.
No takes yet. Share an insight, caveat, or question.
Digby et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: